Cost-Effectiveness Analysis of Universal Screening for
Subclinical Hypothyroidism in Pregnancy Based on the Czech
Nation-Wide Pilot Screening Program in Light of Current
Evidence

J 2025

Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence

TUŽIL, Jan; Jan JISKRA; Marcela KOUDELKOVÁ; Renata CHLOUPKOVÁ; Kateřina HEJCMANOVÁ et al.

Základní údaje

Originální název

Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence

Název česky

Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence

Autoři

TUŽIL, Jan; Jan JISKRA; Marcela KOUDELKOVÁ; Renata CHLOUPKOVÁ; Kateřina HEJCMANOVÁ; Ondřej MÁJEK ; Klára TUŽILOVÁ a Jana BARTÁKOVÁ

Vydání

Value in Health Regional Issues, Amsterdam, Elsevier, 2025, 2212-1099

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

domovská stránka

Impakt faktor

Impact factor: 1.500 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00141621

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

cost effectiveness; hypothyroidism; pregnancy; screening; thyroid; TPO; TSH

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 2. 2026 09:54, Mgr. Tereza Miškechová

Anotace

ORIG CZ

V originále

Universal screening of TSH and extension with anti-TPO appear to be cost-effective. The population benefits of TSH screening are modest, but the BI is low. The model for anti-TPO is based on weak evidence and generates important BI.

Česky

Univerzální screening TSH a rozšíření o anti-TPO se jeví jako nákladově efektivní. Přínos screeningu TSH pro populaci je mírný, ale BI je nízké. Model pro anti-TPO je založen na slabých důkazech a generuje významné BI.

Citovat

TUŽIL, Jan; Jan JISKRA; Marcela KOUDELKOVÁ; Renata CHLOUPKOVÁ; Kateřina HEJCMANOVÁ; Ondřej MÁJEK; Klára TUŽILOVÁ a Jana BARTÁKOVÁ. Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence. Value in Health Regional Issues. Amsterdam: Elsevier, 2025, roč. 49, September 2025, s. 1-12. ISSN 2212-1099. Dostupné z: https://doi.org/10.1016/j.vhri.2025.101145.

@article{2508604,
   author = {Tužil, Jan and Jiskra, Jan and Koudelková, Marcela and Chloupková, Renata and Hejcmanová, Kateřina and Májek, Ondřej and Tužilová, Klára and Bartáková, Jana},
   article_location = {Amsterdam},
   article_number = {September 2025},
   doi = {https://doi.org/10.1016/j.vhri.2025.101145},
   keywords = {cost effectiveness; hypothyroidism; pregnancy; screening; thyroid; TPO; TSH},
   language = {eng},
   issn = {2212-1099},
   journal = {Value in Health Regional Issues},
   title = {Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence},
   url = {https://www.valuehealthregionalissues.com/article/S2212-1099(25)00070-6/fulltext},
   volume = {49},
   year = {2025}
}

TY  - JOUR
ID  - 2508604
AU  - Tužil, Jan - Jiskra, Jan - Koudelková, Marcela - Chloupková, Renata - Hejcmanová, Kateřina - Májek, Ondřej - Tužilová, Klára - Bartáková, Jana
PY  - 2025
TI  - Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence
JF  - Value in Health Regional Issues
VL  - 49
IS  - September 2025
SP  - 1-12
EP  - 1-12
PB  - Elsevier
SN  - 22121099
KW  - cost effectiveness
KW  - hypothyroidism
KW  - pregnancy
KW  - screening
KW  - thyroid
KW  - TPO
KW  - TSH
UR  - https://www.valuehealthregionalissues.com/article/S2212-1099(25)00070-6/fulltext
N2  - Universal screening of TSH and extension with anti-TPO appear to be cost-effective. The population benefits of TSH screening are modest, but the BI is low. The model for anti-TPO is based on weak evidence and generates important BI.
ER  -

TUŽIL, Jan; Jan JISKRA; Marcela KOUDELKOVÁ; Renata CHLOUPKOVÁ; Kateřina HEJCMANOVÁ; Ondřej MÁJEK; Klára TUŽILOVÁ a Jana BARTÁKOVÁ. Cost-Effectiveness Analysis of Universal Screening for Subclinical Hypothyroidism in Pregnancy Based on the Czech Nation-Wide Pilot Screening Program in Light of Current Evidence. \textit{Value in Health Regional Issues}. Amsterdam: Elsevier, 2025, roč.~49, September 2025, s.~1-12. ISSN~2212-1099. Dostupné z: https://doi.org/10.1016/j.vhri.2025.101145.

Přehled o publikaci